Chiara Fabris1, Andrea Facchinetti1, Giuseppe Fico2, Francesco Sambo1, Maria Teresa Arredondo2, Claudio Cobelli3. 1. Department of Information Engineering, University of Padova, Padova, Italy. 2. Life Supporting Technologies Group, Dpt. TBF - Photonic Technology and Bioengineering, Technical University of Madrid, Madrid, Spain. 3. Department of Information Engineering, University of Padova, Padova, Italy cobelli@dei.unipd.it.
Abstract
BACKGROUND: Abnormal glucose variability (GV) is a risk factor for diabetes complications, and tens of indices for its quantification from continuous glucose monitoring (CGM) time series have been proposed. However, the information carried by these indices is redundant, and a parsimonious description of GV can be obtained through sparse principal component analysis (SPCA). We have recently shown that a set of 10 metrics selected by SPCA is able to describe more than 60% of the variance of 25 GV indicators in type 1 diabetes (T1D). Here, we want to extend the application of SPCA to type 2 diabetes (T2D). METHODS: A data set of CGM time series collected in 13 T2D subjects was considered. The 25 GV indices considered for T1D were evaluated. SPCA was used to select a subset of indices able to describe the majority of the original variance. RESULTS: A subset of 10 indicators was selected and allowed to describe 83% of the variance of the original pool of 25 indices. Four metrics sufficient to describe 67% of the original variance turned out to be shared by the parsimonious sets of indices in T1D and T2D. CONCLUSIONS: Starting from a pool of 25 indices assessed from CGM time series in T2D subjects, reduced subsets of metrics virtually providing the same information content can be determined by SPCA. The fact that these indices also appear in the parsimonious description of GV in T1D may indicate that they could be particularly informative of GV in diabetes, regardless of the specific type of disease.
BACKGROUND:Abnormal glucose variability (GV) is a risk factor for diabetes complications, and tens of indices for its quantification from continuous glucose monitoring (CGM) time series have been proposed. However, the information carried by these indices is redundant, and a parsimonious description of GV can be obtained through sparse principal component analysis (SPCA). We have recently shown that a set of 10 metrics selected by SPCA is able to describe more than 60% of the variance of 25 GV indicators in type 1 diabetes (T1D). Here, we want to extend the application of SPCA to type 2 diabetes (T2D). METHODS: A data set of CGM time series collected in 13 T2D subjects was considered. The 25 GV indices considered for T1D were evaluated. SPCA was used to select a subset of indices able to describe the majority of the original variance. RESULTS: A subset of 10 indicators was selected and allowed to describe 83% of the variance of the original pool of 25 indices. Four metrics sufficient to describe 67% of the original variance turned out to be shared by the parsimonious sets of indices in T1D and T2D. CONCLUSIONS: Starting from a pool of 25 indices assessed from CGM time series in T2D subjects, reduced subsets of metrics virtually providing the same information content can be determined by SPCA. The fact that these indices also appear in the parsimonious description of GV in T1D may indicate that they could be particularly informative of GV in diabetes, regardless of the specific type of disease.
Authors: Jan Šoupal; Jan Škrha; Martin Fajmon; Eva Horová; Miloš Mráz; Jan Škrha; Martin Prázný Journal: Diabetes Technol Ther Date: 2014-01-08 Impact factor: 6.118
Authors: Edmond A Ryan; Tami Shandro; Kristy Green; Breay W Paty; Peter A Senior; David Bigam; A M James Shapiro; Marie-Christine Vantyghem Journal: Diabetes Date: 2004-04 Impact factor: 9.461
Authors: Giada Acciaroli; Giovanni Sparacino; Liisa Hakaste; Andrea Facchinetti; Giorgio Maria Di Nunzio; Alessandro Palombit; Tiinamaija Tuomi; Rafael Gabriel; Jaime Aranda; Saturio Vega; Claudio Cobelli Journal: J Diabetes Sci Technol Date: 2017-06-01
Authors: Julie Wagner; Stephen Armeli; Howard Tennen; Angela Bermudez-Millan; Howard Wolpert; Rafael Pérez-Escamilla Journal: Psychosom Med Date: 2017-09 Impact factor: 4.312
Authors: Julie Wagner; Stephen Armeli; Howard Tennen; Angela Bermudez-Millan; Howard Wolpert; Rafael Pérez-Escamilla Journal: J Behav Med Date: 2020-06-03